$IXHL On News! Incannex Completes Share Sale and P
Post# of 41779
![Avatar](/images/ProfileImages/982093748_22164_no_avatar_available.jpg)
MELBOURNE, Australia, May 12, 2022 /PRNewswire/ -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), ('Incannex' or the 'Company') a clinical-stage pharmaceutical company developing unique medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for unmet medical needs, advises that it has entered into a Share Sale and Purchase Agreement to acquire 100% of the issued share capital in APIRx Pharmaceuticals USA, LLC (APIRx) (Acquisition).
https://finance.yahoo.com/news/incannex-compl...00759.html
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)